Back

Notification report


Full notification file


General information

Notification Number
B/NL/15/011

Member State to which the notification was sent
Netherlands

Date of acknowledgement from the Member State Competent Authority
23/11/2015

Title of the Project
Vaccination of chickens with a herpes virus of turkey vaccine with inserted the F-gene of Newcastle Disease Virus and the VP2 gene of Infectious Bursal Disease Virus.

Proposed period of release:
01/01/2016 to 31/12/2018

Name of the Institute(s) or Company(ies)
Intervet International bv, Boxmeer, The Netherlands;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
The Innovax-ND-IBD vaccine contains the live cell-associated Herpesvirus of Turkey (HVT) strain HVP360 in a cell-associated form. This is a vector vaccine: the HVP360 virus strain was generated by inserting the F-gene of Newcastle Disease Virus (NDV) and the VP2 gene of Infectious Bursal Disease Virus (IBDV) into the HVT strain FC-126 genome.
HVT belongs to the virus family Herpesviridae, subfamily Alphaherpesvirinae, genus "Marek's disease-like viruses" (also known as the genus Mardivirus).


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HVTMardivirusMeleagrid herpesvirus 1-FC-126-

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known